Sun Pharma, CMS develop & commercialize generic products in China

Sun Pharma, CMS to develop & commercialize generic products in China

9:12 AM, 17th August 2019
Sun Pharma logo

MUMBAI, INDIA: Sun Pharmaceutical Industries Ltd has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd (CMS), to develop & commercialize seven generic products in Mainland, China.

The collaboration with CMS now covers eight generic products including the seven products referred above.

The total addressable market size for all these eight products is about $1 billion (as per recent IQVIA data) in Mainland China. The initial term of the agreement shall be 20 years from the first commercial sale of the respective products in Mainland China and may be extended for additional three years’ as per mutual agreement of the two parties.

In June 2019, Sun Pharma had announced collaboration with CMS on two speciality products, Tildrakizumab and Cyclosporine A 0.09% (CsA) eye drops for the Greater China market.

“This collaboration gives us entry into the Chinese generic pharmaceutical market. We see lot of potential in China for both, our generics and speciality portfolio. With more than 65% generics penetration, China represents a significant opportunity for generic pharmaceutical companies,” said Dilip Shanghvi, Managing Director, Sun Pharma.

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Zoetis completes acquisition of nutrition-focused animal health company

PARSIPPANY/BUELLTON, US: Zoetis Inc has completed the acquisition of Platinum Performance, a privately-held nutrition-focused animal health company. ...

Read more
SGL CEO resigns following weaker financial performance in July

WIESBADEN, GERMANY: SGL Carbon said that its CEO Jurgen Kohler has resigned after the company tumbles its full-year earnings guidance following a weak ...

Read more
Elkem acquires Korean specialty silicone gels producer Basel Chemie

OSLO, NORWAY: Elkem ASA acquires Basel Chemie, a Korean producer of specialty silicone gels for cosmetics and water repellents for the construction in ...

Read more
Behr Paint unveils 2020 colour of the year: Back to Nature

CALIFORNIA, US: Behr Paint has unveiled Back to Nature S340-4 as its 2020 Colour of the Year. It perfectly captures the essence of subtle and effortle ...

Read more
Praj Industries, Dedini to provide ethanol production technologies in Brazil

PUNE, INDIA: Praj Industries has entered into a cooperation agreement with Dedini S/A Indústrias de Base to provide ethanol production technolo ...

Read more
Roche's personalized cancer treatment wins FDA approval

BASEL, SWITZERLAND: The US Food and Drug Administration approved Roche Holding AG's personalized cancer treatment, which targets tumors with specific ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X